详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Xu Wei[1,*1] * ; Yang Shenmiao[2] ; Zhou Keshu[3] ; Pan Ling[4] ; Li Zengjun[5] ; Gao Sujun[6] ; Zhou Daobin[7] ; Hu Jianda[8] ; Feng Ru[9] ; Huang Haiwen[10] ; Wang Tingyu[5] ; Li Dengju[11] ; Ji Meng[12,13,14] ; Guo Haiyi[12,13,14] ; Zhao Xia[12,13,14] ; Wu Binghao[12,13,14] ; Yu Yiling[12,13,14] ; Wang Yu[12,13,14] ; Huang Jane[12,13,14] ; Novotny William[12,13,14] ; Li Jianyong[1,*2] ;

机构： [1]Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing, China [2]Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing, China [3]Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China [4]West China Hospital of Sichuan University, Chengdu, China [5]Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, China [6]The First Hospital of Jilin University, Changchun, China [7]Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China [8]Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China [9]Nanfang Hospital of Southern Medical University, Guangzhou, China [10]The First Hospital of Soochow University, Suzhou, China [11]Tongji Hospital, Tongji Medical College, Wuhan, China [12]BeiGene (Beijing) Co., Ltd., Beijing, China [13]BeiGene (Shanghai) Co., Ltd., Shanghai, China [14]BeiGene USA, Inc., San Mateo, CA, USA

出处：

DOI：

ISSN：

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 4 区医学

小类 | 4 区血液学 4 区肿瘤学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区血液学 4 区肿瘤学

JCR分区：

出版当年[2023]版：

Q3 ONCOLOGY Q3 HEMATOLOGY

最新[2023]版：

Q3 ONCOLOGY Q3 HEMATOLOGY

第一作者：

第一作者机构： [1]Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing, China [*1]Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine, 300 Guangzhou Road, Nanjing, China

通讯作者：

通讯机构： [1]Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing, China [*1]Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine, 300 Guangzhou Road, Nanjing, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis

文献详情